⌘K
Loading ticker…
As of 2026-08-24, Cabaletta Bio, Inc. Common Stock (CABA) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.9%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CABA is in a stage 3 topping pattern, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 7.6% / 8.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CABA is held by 3 ETFs as of May 2026. Top owner: AVSC at 0.00% weight, $66K notional. Top 3 carry $98K.
Held by 12 ETFs · $15M across latest filings · largest weight 0.58% (TMED).
Top 3 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CABA Jan avg: 11.16% median: 11.32% win: 75% σ: 17.67% n: 4 2022-04-12 → 2026-07-31 | CABA Feb avg: -2.76% median: -6.38% win: 50% σ: 27.77% n: 4 2022-04-12 → 2026-07-31 | CABA Mar avg: -18.53% median: -21.12% win: 0% σ: 8.49% n: 4 2022-04-12 → 2026-07-31 | CABA Apr avg: -6.44% median: -4.69% win: 40% σ: 26.03% n: 5 2022-04-12 → 2026-07-31 | CABA May avg: 10.76% median: -2.79% win: 40% σ: 21.99% n: 5 2022-04-12 → 2026-07-31 | CABA Jun avg: -10.46% median: -17.72% win: 20% σ: 21.80% n: 5 2022-04-12 → 2026-07-31 | CABA Jul avg: -0.42% median: 0.00% win: 40% σ: 9.68% n: 5 2022-04-12 → 2026-07-31 | CABA Aug avg: -10.11% median: -11.84% win: 25% σ: 11.85% n: 4 2022-04-12 → 2026-07-31 (current) | CABA Sep avg: 5.20% median: -4.34% win: 50% σ: 40.81% n: 4 2022-04-12 → 2026-07-31 | CABA Oct avg: 45.78% median: 23.98% win: 50% σ: 83.27% n: 4 2022-04-12 → 2026-07-31 | CABA Nov avg: 39.11% median: 10.08% win: 75% σ: 85.99% n: 4 2022-04-12 → 2026-07-31 | CABA Dec avg: 23.14% median: 13.32% win: 50% σ: 65.26% n: 4 2022-04-12 → 2026-07-31 |